GlassScriptPhysician profile
Asit P Patel
NPI 1083644181
$1,567.43
in general payments reported to CMS, 2019-2025
15 companies · $21.45 in 2025
The $21.45 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $229 · 2021: $268 · 2022: $116 · 2023: $120 · 2024: $236 · 2025: $21.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $430.86 | 2019-2024 | Belbuca, Xtampza |
| Daiichi Sankyo INC. | $254.51 | 2019 | |
| Medtronic, INC. | $216.15 | 2022-2024 | Intellis Adaptivestim, Interstim |
| Biodelivery Sciences International, INC. | $148.69 | 2019-2021 | |
| Grt US Holding, INC. | $87.26 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $70.20 | 2019 | |
| Boston Scientific Corporation | $61.06 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $58.14 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.14 | 2020-2023 | Relistor |
| Redhill Biopharma INC. | $49.05 | 2020-2021 | |
| Nevro Corp. | $43.35 | 2021-2024 | Senza |
| Biotissue Holdings INC. | $36.52 | 2021 | |
| Foundation Fusion Solutions, LLC | $26.73 | 2021 | |
| Valinor Pharma, LLC | $18.59 | 2024 | Movantik |
| Astrazeneca Pharmaceuticals LP | $13.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.